NCT07353918
Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy
Enrolling by Invitation
NAAges 18–85InterventionalTreatmentCarilion ClinicInvestigator-initiated
~6 participants
Updated 2026-01-21 on ClinicalTrials.gov
What's tested:Low-intensity Focused UltrasoundSham
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Seizure Frequency
Measured over 6 months past their final research study visit
Conditions
Where it's being run
1 sites across 1 statesVirginia1
Study leadership
- Aashit Shah, MD · PRINCIPAL_INVESTIGATOR · Carilion Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Diagnosis of medically refractory focal epilepsy of mesial temporal onset
RNS system implantation in the hippocampus
Prior MRI and CT of the head
Able to consent for themselves
Internet access
Exclusion
TBI (ongoing, or in the prior 6 months)
Currently pregnant or breastfeeding
Progressive diseases - such as autoimmune epilepsies or diagnosis of a progressive neurological disorder
Status epilepticus within one year of study start
History of suicidal ideation or attempts in the last 6 months
What this trial measures
- Seizure Frequency6 months past their final research study visit
Utilizing the implanted RNS system patient seizure frequency will be monitored over time following both real and sham intervention.